Clinical Trial

Investigating the Tumour Immune Response of Radiotherapy

Study acronym: TIMM-RAD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 11, 2025 (before its estimated July 14, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to investigate immune changes which occur before and following standard radiotherapy in a range of tumour types. We will collect tissue and blood samples before and after radiation treatment from participants across six cancer types: cervical, rectal, Head and Neck cancer, nodal non-Hodgkin lymphoma, cutaneous lymphoma and cutaneous squamous cell carcinoma/ basal cell carcinoma.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-09-30; most recent amendment 2025-06-05.
Trial Details
NCT Number NCT05076500
Lead Sponsor University of Manchester
Collaborators: The Christie NHS Foundation Trust
Conditions Cancer
Enrollment 120 participants
Start Date 2021-07-14
Primary Completion 2026-07-14 (estimated)
Study Completion 2026-08-14 (estimated)
Updated on ClinicalTrials.gov 2025-06-11